Wainberg, Z. A., Link, J. M., Premji, A., Zheng, S., Srienc, M., Hammons, M., Kim, S. E., Li, L., Liu, Z., Tsvetkova, O., Abt, E. R., Rosen, L., Kim, S., King, J., Hines, O. J., Girgis, M., Sadeghi, S., Olevsky, O., Wong, D., Yonemoto, L., Siney, A. M., Kelly, K., Kivork, C., Tseng, C., Radu, C. G., Dawson, D. W., Donahue, T. R. (2026). Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial. Nature Communications. https://doi.org/10.1038/s41467-026-68976-2